About HETERO
HETERO is a Healthcare company. Production of anti-retroviral and anti-cancer pharmaceuticals in Russia. HETERO offers products and services including Anti-Retroviral Drugs and Anti-Cancer Drugs. Its focus areas include Manufacturing, API and Formulations, Oncology Drugs and Pharmaceuticals. Its legal entity in India is ΠΠΠ 'ΠΠΠΠΠ-Π€ΠΠ ΠΠ' (U99999MH1977PLC010754).
Company details
HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ООО МАКИЗ-ФАРМА in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website heteroworld.ru
- Legal Name Ооо 'Макиз-Фарма'
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of HETERO
HETERO operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | View details |
Products & Services of HETERO
HETERO offers a comprehensive portfolio of products and services, including Anti-Retroviral Drugs and Anti-Cancer Drugs.
Anti-retroviral drugs are manufactured for affordable treatment of viral conditions
Various anti-cancer medications are produced in forms such as tablets and infusions for effective disease management
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Hetero
Complete news archive for HETERO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HETERO
HETERO is recognized for its role in manufacturing a wide range of anti-retroviral and anti-cancer drugs at affordable prices, with operations centered in Russia. The primary production site, operated by ΠΠΠ ΠΠΠΠΠ-Π€ΠΠ ΠΠ in Moscow, focuses on creating non-sterile forms like tablets and capsules that adhere to global standards. Quality control is handled by independent experts, and collaborations with partners are emphasized to enhance access to effective treatments. Efforts are directed towards building full-cycle production facilities that support modern healthcare needs, ensuring safety and efficacy in all products.
HETERO offers Anti-Retroviral Drugs and Anti-Cancer Drugs.
HETERO operates through ,.

